AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Scholar RockVericelMesoblastDBV TECHNOLOGIE/SAptose Biosciences
SymbolNASDAQ:SRRKNASDAQ:VCELNASDAQ:MESONASDAQ:DBVTNASDAQ:APTO
Price Information
Current Price$18.40$14.38$12.65$4.87$7.38
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.61.71.21.72.0
Analysis Score3.54.42.44.33.5
Community Score2.32.43.12.42.7
Dividend Score0.00.00.00.00.0
Ownership Score2.01.00.01.04.0
Earnings & Valuation Score0.00.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$35.00$24.25$15.04$11.50$12.00
% Upside from Price Target90.22% upside68.64% upside18.86% upside136.14% upside62.60% upside
Trade Information
Market Cap$576.27 million$629.06 million$1.47 billion$522.91 million$541.52 million
Beta0.8133.532.71.68
Average Volume98,369746,516739,090468,973991,795
Sales & Book Value
Annual Revenue$20.49 million$117.85 million$16.72 million$14.75 millionN/A
Price / Sales26.835.5087.8636.27N/A
CashflowN/A$0.20 per shareN/AN/AN/A
Price / CashN/A71.31N/AN/AN/A
Book Value$3.30 per share$2.45 per share$4.82 per share$2.11 per share$1.14 per share
Price / Book5.585.872.622.31N/A
Profitability
Net Income$-51,000,000.00$-9,660,000.00$-89,800,000.00$-172,020,000.00$-26,280,000.00
EPS($1.85)$0.18($0.91)($2.33)($0.52)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A33.44N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-255.69%-9.39%-197.65%N/AN/A
Return on Equity (ROE)-49.59%5.87%-13.60%N/A-53.31%
Return on Assets (ROA)-30.26%4.22%-9.93%N/A-48.99%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.04%0.20%0.15%0.12%N/A
Current Ratio6.06%6.43%1.21%3.79%20.56%
Quick Ratio6.06%6.03%1.21%3.75%20.56%
Ownership Information
Institutional Ownership Percentage63.10%89.94%2.29%44.00%46.09%
Insider Ownership Percentage41.40%4.30%18.80%15.31%7.34%
Miscellaneous
Employees652168124431
Shares Outstanding29.87 million45.11 million116.13 million109.85 million76.27 million
Next Earnings Date8/12/2020 (Estimated)8/4/2020 (Estimated)9/3/2020 (Estimated)N/A8/4/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.